SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cortex (Cor) [formerly CORX]
COR 355.25+0.5%9:38 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: GR who wrote (557)10/19/1998 9:10:00 AM
From: Michael Olin  Read Replies (2) of 1255
 
The compounds (Ampakines) were mentioned in an NBC Nightly News story about memory loss at the end of 1996 and a cover story in a West coast newspaper (I think the LA Times) the following morning. The stock spiked from $3 and change to almost $7. Either someone at NBC is keeping an eye on Cortex (back burner sort of stuff, waiting for some significant news) or they just happen to be doing the same story every couple of years. I think that the May 1998 spike was related to promising schizophrenia results, not memory loss.

Today should be interesting. Considering that I've been holding this one since the pre-hype $7 days, I doubt that anything other than an announced partnership or definitive results from the NIH trials will do much for my position. Then again, I knew that buy-and-hold would only make me money on CORX if they got a compound to market when I bought the stock. Good luck to all the traders and the handful of LONG-suffering investors like me out there.

-Michael
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext